Page 12 - Activating Construct News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Activating construct. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Activating Construct Today - Breaking & Trending Today

Equities Analysts Issue Forecasts for Harpoon Therapeutics, Inc.'s FY2027 Earnings (NASDAQ:HARP)

Harpoon Therapeutics, Inc. (NASDAQ:HARP – Get Rating) – Equities researchers at HC Wainwright issued their FY2027 EPS estimates for Harpoon Therapeutics in a research note issued to investors on Wednesday, March 29th. HC Wainwright analyst S. Ramakanth expects that the company will earn $0.23 per share for the year. HC Wainwright has a “Buy” rating […] ....

Ronald Hunt , Harpoon Therapeutics Company Profile , Blackrock Inc , Renaissance Technologies , Dimensional Fund Advisors , Vanguard Group Inc , Harpoon Therapeutics Inc , Sequoia Financial Advisors , Harpoon Therapeutics , Get Rating , Harpoon Therapeutic , Truist Financial , Director Ronald Hunt , Fund Advisors , Financial Advisors , Activating Construct , Harpoon Therapeutics Daily , Nasdaq Harp , Earnings Estimates , Hc Wainwright ,

Harpoon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

HPN217 and HPN328 enrollment on track, with data updates and selection of recommended Phase 2 doses for both active clinical programs planned in 2023 Completion of $25 million preferred. | March 27, 2023 ....

United States , Roberth Uhl , Luke Walker , Julie Eastland , American Society Of Hematology , Harpoon Development , Harpoon Therapeutics Inc , Exchange Commission , Chief Executive Officer , Upcoming Highlights , Activating Construct , American Society , Annual Meeting , Fast Track , Five Preclinical Posters , Chief Medical , Full Year , Restated Collaboration Agreement , Option Agreement , Harpoon Therapeutics , Forward Looking Statements , Private Securities Litigation Reform Act , Harpoon Therapeutic , Months Ended December , Nc Stock Exchange , Press Release ,

Harpoon Therapeutics Announces Acceptance of Five Abstracts for Presentation at AACR Annual Meeting 2023

Harpoon Therapeutics Announces Acceptance of Five Abstracts for Presentation at AACR Annual Meeting 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Roberth Uhl , Kerry Walton , Julie Eastland , Exchange Commission , American Association For Cancer Research , Harpoon Therapeutics Inc , Activating Construct , American Association , Cancer Research , Annual Meeting , Chief Executive Officer , Poster Section , Tuesday April , Therapeutic Antibodies , Monday April , Harpoon Therapeutics , Private Securities Litigation Reform Act , Harpoon Therapeutic ,

Harpoon Therapeutics Announces Acceptance of Five Abstracts for Presentation at AACR Annual Meeting 2023

Harpoon Therapeutics Announces Acceptance of Five Abstracts for Presentation at AACR Annual Meeting 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Westwickeroberth Uhlmanaging , Communicationskerry Walton , Julie Eastland , Exchange Commission , American Association For Cancer Research , Harpoon Therapeutics Inc , Wall Street , Activating Construct , American Association , Cancer Research , Annual Meeting , Chief Executive Officer , Abstract Number , Poster Section , Tuesday April , Session Date , Therapeutic Antibodies , Monday April , Harpoon Therapeutics , Private Securities Litigation Reform Act , Harpoon Therapeutic , Managing Director , Uncapped Communicationskerry Walton ,

Harpoon Therapeutics to Participate in the SVB Securities Global Biopharma Conference

07.02.2023 - SOUTH SAN FRANCISCO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) - Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immuno-oncology company developing novel T cell engagers, today announced that management will present at the virtual SVB . ....

Roberth Uhl , About Harpoon , Activating Construct , Harpoon Therapeutics ,